CRAMS Industry

  • INR 40000
  • USD 700
Subscribe Now

Annual Review

Impact Analysis

  • CRAMS growth rate moderates, but prospects remains intact…

    With branded drugs worth ~US$105bn going off-patent by FY20, global pharmaceutical companies are expected to enhance their allocations to R&D to incre.....

    + Know More

Healthcare Coverage

Related Reports

Get Alerts

To receive CARE Research publications and alerts.

Register Now >>